Home > Boards > Commodities > Energy > Oil & Gas - Energy - Commodities - Resources

Earnings Previews: Marathon Petroleum (MPC),...

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
DiscoverGold Member Profile
Member Level 
Followed By 579
Posts 80,078
Boards Moderated 45
Alias Born 03/10/04
160x600 placeholder
Activision on Track for Longest Losing Streak Since January 2014 -- Data Talk
Activision Blizzard, Inc. (ATVI) is currently at $59.59, down $0.72 or 1.19%
Cumberland Pharmaceuticals Shares Double, Hit 52-Week High
STOXX Europe 600 Index Ends the Month 2.64% Lower at 462.96 -- Data Talk
FTSE 100 Index Ends the Month 2.46% Lower at 7059.45 -- Data Talk
DAX Ends the Month 3.75% Lower at 15100.13 -- Data Talk
CAC 40 Index Ends the Month 1.60% Lower at 6721.16 -- Data Talk
STOXX Europe 50 Index Ends the Month 2.57% Lower at 3593.42 -- Data Talk
EURO STOXX 50 Index Ends the Month 4.41% Lower at 4063.06 -- Data Talk
U.S. Crude-Oil Stockpiles Likely Decreased in DOE Data, Analysts Say
FTSE Closes Down as Omicron Variant Sparks Volatility
Cabot Properties Sells Logistics Portfolio to Blackstone for $2.8 Billion
Oersted Secures 12-Year Power Purchase Contract With Google
Array Technologies Shares Fall With Plans for Convertible Notes Offering
U.S. Ethanol Production and Stocks Estimates for Nov. 26
Top Company News of the Day
TG Therapeutics Shares Drop 38% After Plans for Advisory Meeting
Consumer Confidence Fell in November Amid Inflation Worries
Clarus Therapeutics Shares Rise 27% on New U.S. Patents
Unemployment Rate Seen Ticking Down Again -- Data Week Ahead
MEI Pharma Shares Rise 22% After Positive Data for Zandelisib Trial
TG Therapeutics Shares Drop 35% Premarket After FDA Plans for Advisory Meeting
Codiak BioSciences Gets FDA Approval for ExoASO-STAT6 IND Application
MTN Group to Cut Stake in MTN Nigeria Via Share Placing
AbbVie Submits Europe Application for Risankizumab for Crohn's Disease
Hepion Pharmaceuticals Gets Fast-Track Designation for NASH Treatment
NextEra to Sell 50% Stake in Renewables Portfolio to Ontario Teachers' Pension Plan
Right Time for New Leadership, Inditex Chairman Says, as Founder's Daughter Prepares to Take His Place -- Update
Stellantis, Daimler's Mercedes-Benz Invest in Battery Maker Factorial Energy
FTSE Drops, John Menzies Seen Poised to Recover Strongly From Pandemic
DiscoverIE Group 1st Half Sales Hampered by Sterling -- Currency Comment
AstraZeneca: Lynparza Gets FDA Priority Review -- Update
DiscoverGold Member Level  Monday, 08/02/21 02:28:15 PM
Re: None
Post # of 6227 
Earnings Previews: Marathon Petroleum (MPC),...
By: 24/7 Wall St. | August 2, 2021

Marathon Petroleum

The country’s largest oil refiner, Marathon Petroleum Corp. (NYSE: MPC), has seen its share price rise by nearly 50% over the past 12 months. For the year to date, the stock has added about 34%. Rising oil prices are generally a drag on refining margins and earnings, and that trend has not escaped the notice of analysts who see Marathon’s revenues flattening or even declining for the rest of the year.

Even so, of 16 brokerages covering Marathon, 12 rate the shares a Buy or Strong Buy, and the rest recommend holding the stock. At a trading price of around $54.40, the stock’s upside potential based on a median price target of $70 is about 29%. At the high target of $83, upside potential is nearly 53%.

Quarterly revenue is forecast at $21.24 billion, down more than 7% sequentially, but up by about 46% year over year. In the same quarter last year, Marathon posted an adjusted loss per share of $1.33. For the second quarter of 2021, analysts are looking for EPS of $0.38. For the full year, the consensus estimates call for EPS of $0.88, compared to a 2020 loss per share of $3.44. Revenue is forecast to rise by 26.5% to $87.32 billion.

Marathon’s stock trades at 60.8 times expected 2021 EPS, 16.6 times estimated 2022 earnings and 12.7 times estimated 2023 earnings. The stock’s 52-week range is $26.56 to $64.84. Marathon pays an annual dividend of $2.32 (yield of 4.2%)...

Read Full Story »»»


Information posted to this board is not meant to suggest any specific action, but to point out the technical signs that can help our readers make their own specific decisions. Caveat emptor!
• DiscoverGold
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences